Chinese English
©2024 cardiocycle. All Rights Reserved.

  • Clinical Cases

    Benefit the public with medical care and expand medical services through innovation.

2024.12.20

Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon Occlusion in Patients with Hepatocellular Carcinoma A Propensity Score Matched Analysis
2024.12.20

Microballoon+Interventions+for+Liver+Tumors+Review+of+Literature+and+Future+Perspectives
2024.12.20

Microballoon Interventions for Liver Tumors Review of Literature and Future Perspectives
2024.12.20

Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepa
2024.12.20

In Vivo Comparison of Micro-Balloon Interventions (MBI) Advantage_ A Retrospective Cohort Study of DEB-TACE Versus b-TACE and of(科研通-ablesci.com)
2024.12.20

Balloon-occluded+transcatheter+arterial+chemoembolization+for+hepatocellular+carcinoma
2024.12.20

Balloon-occluded_transcatheter_arterial_chemoembol
2024.12.20

Balloon+occluded+TACE+(B-TACE)+vs+DEM-TACE+for+HCC
  • Contact
  • CardioCycle Technology (Suzhou) Co., Ltd.
  • Address: Unit 401&501, Building C15, Stage 5, BioBAY, No.21 Chaoqian Road, Suzhou Industrial Park, China
    Telephone: 0086 512-62520838
    E-mail: hx@cardiocycle.com.cn

Cardiocycle WeChat

©2024 CardioCycle Medical（Suzhou）Co.,Ltd. All Rights Reserved.
环心医疗官方公众号